NITIN SOOD - 16 Aug 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Chief Commercial Officer
Signature
/s/ Nitin Sood by Eric Billings, attorney-in-fact
Issuer symbol
ADPT
Transactions as of
16 Aug 2021
Net transactions value
$0
Form type
4
Filing time
18 Aug 2021, 18:21:22 UTC
Previous filing
13 Aug 2021
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Award $0 +97,213 $0.000000 97,213 16 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Award $0 +162,022 $0.000000 162,022 16 Aug 2021 Common Stock 162,022 $30.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest with respect to 1/4 of such shares on August 4, 2022, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.